Bausch Health Companies Inc.
BHC
$8.62
$0.060.70%
| Weiss Ratings | BHC - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | BHC - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Fair | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | BHC - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.30 | |||
| Price History | BHC - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -1.60% | |||
| 30-Day Total Return | -5.48% | |||
| 60-Day Total Return | 5.38% | |||
| 90-Day Total Return | 20.22% | |||
| Year to Date Total Return | 10.80% | |||
| 1-Year Total Return | 14.02% | |||
| 2-Year Total Return | -59.87% | |||
| 3-Year Total Return | -70.93% | |||
| 5-Year Total Return | -63.27% | |||
| 52-Week High % Change | -26.27% | |||
| 52-Week Low % Change | 51.70% | |||
| Price | BHC - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $11.46 | |||
| 52-Week Low Price | $5.57 | |||
| 52-Week Low Price (Date) | May 12, 2023 | |||
| 52-Week High Price (Date) | Apr 03, 2024 | |||
| Valuation | BHC - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 3.19B | |||
| Enterprise Value | 25.78B | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -1.63 | |||
| Earnings Per Share Growth | 161.37% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.35 | |||
| Price/Book (Q) | -3.11 | |||
| Enterprise Value/Revenue (TTM) | 2.93 | |||
| Price | $8.62 | |||
| Enterprise Value/EBITDA (TTM) | 8.94 | |||
| Enterprise Value/EBIT | 15.97 | |||
| Market Cap Category | Mid Cap | |||
| Dividends and Shares | BHC - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 354.55M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | BHC - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 514 744 6792 | |||
| Address | 2150 St. ElzEar Boulevard West Laval, QC H7L 4A8 | |||
| Website | www.bauschhealth.com | |||
| Country | Canada | |||
| Year Founded | -- | |||
| Profitability | BHC - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 18.37% | |||
| Profit Margin | -6.76% | |||
| Management Effectiveness | BHC - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 3.79% | |||
| Return on Equity | -- | |||
| Income Statement | BHC - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 8.66B | |||
| Total Revenue (TTM) | 8.76B | |||
| Revenue Per Share | $24.70 | |||
| Gross Profit (TTM) | 6.20B | |||
| EBITDA (TTM) | 2.87B | |||
| EBIT (TTM) | 1.61B | |||
| Net Income (TTM) | -592.00M | |||
| Net Income Avl. to Common (TTM) | -592.00M | |||
| Total Revenue Growth (Q YOY) | 9.80% | |||
| Earnings Growth (Q YOY) | 88.54% | |||
| EPS Diluted (TTM) | -1.63 | |||
| EPS Diluted Growth (Q YOY) | 90.28% | |||
| Balance Sheet | BHC - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 947.00M | |||
| Cash Per Share (Q) | $2.67 | |||
| Total Current Assets (Q) | 5.60B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -82.00M | |||
| Current Ratio (Q) | 1.301 | |||
| Book Value Per Share (Q) | -$2.80 | |||
| Total Assets (Q) | 27.35B | |||
| Total Current Liabilities (Q) | 4.30B | |||
| Total Debt (Q) | 22.60B | |||
| Total Liabilities (Q) | 27.43B | |||
| Total Common Equity (Q) | -1.02B | |||
| Cash Flow | BHC - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -2.15B | |||
| Cash from Financing (TTM) | 1.48B | |||
| Net Change in Cash (TTM) | 371.00M | |||
| Levered Free Cash Flow (TTM) | 730.63M | |||
| Cash from Operations (TTM) | 1.03B | |||
